The Patent Finder

Yungjin Pharmaceutical Co., Ltd.

Also on record
Records under this name other than the patents Yungjin Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 7 of 7 · Back to Yungjin Pharmaceutical Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,999,646Method of Treating Inflammation, Allergy and Asthma with a Purified Extract (ATC1) Isolated from Pseudolysimachion Rotundum Var. Subintegrum Containing Abundant Amount of Active Ingredient
Held by another company
In force
 · High confidence
In forceHigh confidence
US 10,046,019Purified Extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
Held by another company
In force
 · High confidence
In forceHigh confidence
US 10,172,816Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside
Held by another company
In force
 · Medium confidence
In forceMedium confidence
US 7,009,053Quinoline Derivatives as CASPASE-3 Inhibitor, Preparation for Producing the Same and Pharmaceutical Composition Comprising the Same
Lapsed on the fee record
Ended Mar 7, 2018 · High confidence
Lapsed on the fee recordEnded Mar 7, 2018High confidence
US 6,043,373Heterocycle-fused thiazole derivatives
Lapsed on the fee record
Ended Mar 28, 2008 · USPTO record
Lapsed on the fee recordEnded Mar 28, 2008USPTO record
US 5,731,007Pharmaceutical composition for skin diseases
Term ended
Term ended no later than Mar 24, 2018 · Low confidence
Term endedTerm ended no later than Mar 24, 2018Low confidence
US 5,952,5044-Amino-3-acylnaphthyridine derivatives
Term ended
Term ended no later than Sep 14, 2019 · Low confidence
Term endedTerm ended no later than Sep 14, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited